Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Chubb
QuintilesIMS
Argus Health
Dow
Farmers Insurance
Deloitte
Teva
AstraZeneca
McKinsey

Generated: February 22, 2018

DrugPatentWatch Database Preview

TOBREX Drug Profile

« Back to Dashboard

Which patents cover Tobrex, and when can generic versions of Tobrex launch?

Tobrex is a drug marketed by Novartis Pharms Corp and Sandoz Inc and is included in three NDAs.

The generic ingredient in TOBREX is tobramycin. There are eighteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tobramycin profile page.
Drug patent expirations by year for TOBREX
Pharmacology for TOBREX
Medical Subject Heading (MeSH) Categories for TOBREX

US Patents and Regulatory Information for TOBREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp TOBREX tobramycin OINTMENT;OPHTHALMIC 050555-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis Pharms Corp TOBREX tobramycin SOLUTION/DROPS;OPHTHALMIC 050541-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc TOBREX tobramycin SOLUTION/DROPS;OPHTHALMIC 062535-001 Dec 13, 1984 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
QuintilesIMS
Citi
Cantor Fitzgerald
Colorcon
Healthtrust
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot